当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2005年第12期
编号:11007119
肿瘤细胞内特异表达TRAIL载体的构建及其在喉癌细胞株Hepa2中的表达
http://www.100md.com 《第四军医大学学报》 2005年第12期
遗传学,,TRAIL;聚合酶链反应;端粒,末端转移酶;启动区(遗传学);基因表达,0引言,1材料和方法,2结果,3讨论
     Cloning of secreted hTRAIL tumor-specific vector and expression in laryngeal carcinoma cell line Hepa2

    CHENG ShiYin1 , ZHANG HuiZhong2,CHEN JianQiu1, ZHANG Li1,HAN MingKun1

    1Department of Otorhinolaryngology, 2Center Laboratory ,Tangdu Hospital, Fourth Military Medical University, Xian 710038, China

    【Abstract】 AIM: To clone human soluble TRAIL cDNA and construct its eukaryotic expression vector to prepare a condition for targeted gene therapy. METHODS: The total RNA was extracted from human peripheral blood lymphocytes. TRAIL gene with interleukin 2 signal peptide was amplified by RTPCR and cloned into the vector pGL3181hTERT promoter downstream to form an eukaryotic vector. Expressing protein was identified by Western Blotting on laryngeal carcinoma cell line Hepa2. RESULTS: Sequence of 613 bp cDNA was obtained. Identified by enzyme digestion and sequence analysis, the recombinant eukaryotic expression vector for TRAIL gene had been successfully constructed. The results of the Western Blotting showed the transfected Hepa2 cell could express TRAIL protein. CONCLUSION: Successful construction of eukaryotic expression vector pGL3181 hTERT/TRAIL provides the possibility for gene therapy of tumor. ......

您现在查看是摘要页,全文长 12424 字符